Redox Diagnostics LLC Information

Redox Diagnostics has developed an efficient and effective test to detect Alzheimer’s disease, a diagnostic assay that is simple and inexpensive. In addition, we are constructing an assay panel that promises to detect mitochondrial diseases and other neurological disorders. Having a test to determine the onset of Alzheimer’s disease will be a gamechanger, enabling early therapy and aiding the development of personalized medicine solutions, helping millions and saving billions. Redox Dx was developed through a research partnership with Dignity Health and Midwestern University and is led by the inventor, Dr. Jon Valla, a long-time member of the Arizona Alzheimer's Consortium. He is assisted in research and business development by Crista Procopio and a comprehensive team, and advised by David McCaleb and Robert S. Green.